9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein
- 26 October 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (21) , 8758-8780
Abstract
P-Glycoprotein (P-gp, ABCB1), multidrug resistance-associated protein 1 (MRP1, ABCC1), and breast cancer resistance protein (BCRP, ABCG2) are the three major ABC transport proteins conferring resistance to many structurally diverse anticancer agents, leading to the phenomenon called multidrug resistance (MDR). Much effort has been put into the development of clinically useful compounds to reverse MDR. Broad-spectrum inhibitors of ABC transport proteins can be of great use in cancers that simultaneously coexpress two or three transporters. In this work, we continued our effort to generate new, potent, nontoxic, and multiply effective inhibitors of the three major ABC transporters. The best compound was active in a very low micromolar concentration range against all three transporters and restored sensitivity toward daunorubicin (P-gp and MRP1) and SN-38 (BCRP) in A2780/ADR (P-gp), H69AR (MRP1), and MDCK II BCRP (BCRP) cells. Additionally, the compound is a noncompetitive inhibitor of daunorubicin (MRP1), calcein AM (P-gp), and pheophorbide A (BCRP) transport.Keywords
This publication has 70 references indexed in Scilit:
- Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and FutureAnnual Review of Pharmacology and Toxicology, 2014
- ABC Efflux Pump-Based Resistance to Chemotherapy DrugsChemical Reviews, 2009
- Development of inhibitors of ATP-binding cassette drug transporters – present status and challengesExpert Opinion on Drug Metabolism & Toxicology, 2008
- Anticancer multidrug resistance mediated by MRP1: Recent advances in the discovery of reversal agentsMedicinal Research Reviews, 2005
- The Role of ABC Transporters in Clinical PracticeThe Oncologist, 2003
- Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded materialThe Journal of Pathology, 2002
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences, 1998
- Inhibitors of MRP1-mediated multidrug resistanceDrugs of the Future, 1998
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976